Manufacturer
13 recalls in our database name LUPIN SOMERSET as the manufacturing or recalling firm.
Of the 13 recalls from LUPIN SOMERSET we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Lupin Pharmaceuticals is recalling 3,444 bottles of Morphine Sulfate Extended-Release Tablets, 100 mg, due to failed impurities and degradation specifications.
Lupin Pharmaceuticals is recalling specific lots of Morphine Sulfate Extended-Release Tablets because they failed impurity and degradation specifications.
Lupin Pharmaceuticals is recalling specific lots of Morphine Sulfate Extended-Release Tablets because they failed impurity and degradation specifications.
Lupin Pharmaceuticals is recalling 10,284 bottles of Morphine Sulfate Extended-Release Tablets, 60 mg, due to failed impurities and degradation specifications.
Lupin Pharmaceuticals is recalling 17,328 bottles of Morphine Sulfate Extended-Release Tablets because they failed impurity and degradation specifications.
Lupin Somerset is recalling Gavilyte-N because orange and cherry flavor packets incorrectly list 'natural lemon flavor' as an ingredient.
Lupin Pharmaceuticals is recalling 24,180 bottles of Fluocinolone Acetonide Topical Solution due to elevated impurities.
Lupin Pharmaceuticals is recalling specific lots of Nitrofurantoin Oral Suspension because the drug was found to contain less active ingredient than required.
Lupin Pharmaceuticals is recalling 2,712 bottles of Fluocinolone Acetonide Topical Solution because stability testing showed total impurities exceeded specifications.
Lupin Pharmaceuticals is recalling specific lots of Morphine Sulfate Extended-Release Tablets because testing found an impurity exceeding safety limits.
Lupin Pharmaceuticals is recalling Nitrofurantoin Oral Suspension because the drug is subpotent and failed content uniformity testing.
Lupin Somerset is recalling Equate ClearLAX laxative bottles due to unfiled NDC numbers on the labels. This is a Class III recall with no reported health risks.
Lupin Pharmaceuticals is recalling 1,672 bottles of Hydrocodone Bitartrate and Acetaminophen tablets in Ohio due to missing labels.